BIOCENTAUR
LIVE

Serial Number

79344812

Owner

R.G.C.C. Holdings AG

Attorney

James R Menker

Filing Date

Mar 30, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIOCENTAUR Trademark

Serial Number: 79344812 • Registration: 7232575

BIOCENTAUR is a trademark filed by R.G.C.C. Holdings AG on March 30, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

R.G.C.C. Holdings AG (80 trademarks)

Baarerstrasse 95

Entity Type: 25

Trademark Details

Filing Date

March 30, 2022

Registration Date

December 5, 2023

Published for Opposition

September 19, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2024 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 7, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 5, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 5, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 17, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 30, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 28, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 25, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2022 REPR